Sourav K. Kundu
Sourav K. Kundu publishes mostly in Surgery, Cardiology and Cardiovascular Medicine and Hematology, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Platelet Disorders and Treatments and Mechanical Circulatory Support Devices.
- World rank
- #3,310,347 of 7,710,434 ranked researchers
- Rank in United States
- #935,139 of 1,627,098
- Works
- 17
- Citations
- 1.2k
- Citations per work
- 72.9
What does Sourav K. Kundu research?
Sourav K. Kundu's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (8%), Engineering (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences955.3%
- Medicine955.3%
- Everything else527.7%
- Life Sciences18.5%
- Physical Sciences18.5%
- Engineering18.5%
- 1Surgery21% of their works
- 2Cardiology and Cardiovascular Medicine17% of their works
- 3Hematology11% of their works
- 4Biomedical Engineering8% of their works
- 5Molecular Biology8% of their works
- 6Pathology and Forensic Medicine6% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Platelet Disorders and Treatments
- Mechanical Circulatory Support Devices
- Cardiac Ischemia and Reperfusion
- Coronary Interventions and Diagnostics
- Angiogenesis and VEGF in Cancer
- Cardiac pacing and defibrillation studies
- Venous Thromboembolism Diagnosis and Management
Which keywords describe Sourav K. Kundu's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Thrombosis, Heart Failure, Aspirin, Clopidogrel, Immune Thrombocytopenic Purpura, Platelets and Extracorporeal Membrane Oxygenation.
- Venous Thromboembolism
- Implantable Cardioverter-Defibrillator
- Antithrombotic Therapy
- Ischemia-Reperfusion Injury
- Cardioprotection
- Extracorporeal Membrane Oxygenation
- Immune Thrombocytopenic Purpura
- Aspirin
- Thrombosis
- Percutaneous Coronary Intervention
- Heart Failure
- Clopidogrel
- Platelets
- Left Ventricular Assist Device
- Coronary Stents
- Myocardial Revascularization
- Cardiac Resynchronization Therapy
- VEGF
- endothelial progenitor cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Percutaneous Coronary Intervention123 topics
- Thrombosis92 topics
- Heart Failure62 topics
- Aspirin51 topic
- Clopidogrel51 topic
- Immune Thrombocytopenic Purpura51 topic
- Platelets51 topic
- Extracorporeal Membrane Oxygenation41 topic
- Left Ventricular Assist Device41 topic
- Cardioprotection31 topic
- Coronary Stents31 topic
- Ischemia-Reperfusion Injury31 topic
- Myocardial Revascularization31 topic
- Antithrombotic Therapy21 topic
- Cardiac Resynchronization Therapy21 topic
- Implantable Cardioverter-Defibrillator21 topic
- VEGF21 topic
- Venous Thromboembolism21 topic
- endothelial progenitor cells21 topic
Where does Sourav K. Kundu work?
Sourav K. Kundu's main affiliation in the publication record is Miami Dade College, United States.
How many publications and citations does Sourav K. Kundu have?
OpenAlex counts 17 works and 1,240 citations for Sourav K. Kundu, an h-index of 10, ranking #3,310,347 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sourav K. Kundu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.